Seeded Aggregation and Transmissible Proteopathy—Creepy Stuff Not Just for Prions Anymore?
proteopathies. Trends Neurosci. 2006 Aug;29(8):438-43. Abstract Selected Primary Papers on Seeding: Bolmont T,
Upcoming Webinars
No Upcoming Webinars AvailableALL WEBINARS
117 RESULTS
You searched papers/targeted-pharmacological-depletion-serum-amyloid-p-component-treatment-human-amyloidosis
Sort By:
- Most Recent
- Most Commented
- Most Relevant
LOAD and eFAD—Different Diseases, Different Hypotheses?
flow. (Editor’s note: see recent paper about connectivity data in young ApoE4 data: Filippini et al.,
Meet New Players, Histone Deacetylase and Sirtuin—Will They Help the Cell Cycle, DNA Repair, and Gene Expression Break Into Alzheimerology’s Major League?
inactivation. Vikram Khurana Dohoon, Li-Huei, congratulations on the great paper! Cdk5 seems to be a central
Calcium in AD Pathogenesis
yes, Cell Calcium paper from De Smedt's group (see Kasri et al., 2006). Please see detailed
The Pathogen Hypothesis
reported in the paper (you can download a copy of this and other relevant papers). The mouse findings were
Sports Concussions, Dementia, and APOE Genotyping: What Can Scientists Tell the Public? What’s Up for Research?
my slides, there's a citation to a recent paper in Acta Neuropath Scand about E4, falls without
Mice on Trial? Issues in the Design of Drug Studies
Webinar paper, so it might be useful for the statistics on the subject). The work is done by Dr.
Targeting Tumor Necrosis Factor—A Therapeutic Strategy for AD
Brewer Yong, we have two recent papers that show major effects of TNFR1 and R2 with age in old rat
Non-coding RNAs in Neurodegeneration
Trinna Cuellar Joel, I agree with you. Some of the papers published in the last year or so demonstrating
APP Family: Clues to Function in Health and AD
The amyloid precursor protein was first cloned in 1987. Twenty years and 4,000+ papers later, the
The AD8: A Brief Screening Tool for Very Mild Dementia
reported results of further evaluation of the AD8 interview in back-to-back papers in Archives of
Susceptibility Testing and Risk Assessment in Alzheimer Disease
the topic of a forthcoming paper. Our preliminary analyses suggest that participants found to be at
Finding NIH Support for Drug Discovery and Development for Neurodegenerative Diseases
Searching for the wherewithal to push on with your work on a promising new Alzheimer therapy? The NIH offers funding for research support at every step of the process, from early drug discovery right through to phase 3 clinical trials, if you know where t
Presenilin Loss of Function—Plan B for AD?
a lively Alzforum discussion when Peter Davies initiated a conversation about a paper from Bart de
Alzheimer Disease—The Fragile X Syndrome Connection
characterized by synaptic pathology and as exemplified by a paper in this month’s PLoS, the two may have
Have a topic idea for a webinar? We would love to hear it. Send an email to webinars [at] alzforum [dot] org.
Current Filters
- Keyword: papers/targeted-pharmacological-depletion-serum-amyloid-p-component-treatment-human-amyloidosis x